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   QSAR MODELING OF ANTIBACTERIAL 
ACTIVITY OF SOME BENZIMIDAZOLE 
DERIVATIVES 
A quantitative structure-activity relationship (QSAR) study has been carried out 
for a training set of 12 benzimidazole derivatives to correlate and predict the 
antibacterial activity of studied compounds against Gram-negative bacteria 
Pseudomonas aeruginosa. Multiple linear regression was used to select the 
descriptors and to generate the best prediction model that relates the structural 
features to inhibitory activity. The predictivity of the model was estimated by 
cross-validation with the leave-one-out method. Our results suggest a QSAR 
model based on the following descriptors: parameter of lipophilicity (logP) and 
hydration energy (HE). Good agreement between experimental and predicted 
inhibitory values, obtained in the validation procedure, indicated the good 
quality of the generated QSAR model. 
Key words: benzimidazole; molecular descriptors; quantitative structure-activity 
relationship; antibacterial activity; Pseudomonas aeruginosa. 
 
 
Quantitative structure-activity relationship (QSAR) 
and quantitative structure-property relationship (QSPR) 
studies are undoubtedly of great importance in mo-
dern chemistry and biochemistry. To obtain a signifi-
cant correlation, it is essential that appropriate des-
criptors be used, regardless of whether they are theo-
retical, empirical or derived from readily available ex-
perimental characteristics of structures. Many des-
criptors reflect simple molecular properties and can 
thus provide insight into the physicochemical nature 
of the activity/property under consideration [1-3]. 
Activities used in QSAR include chemical mea-
surements and biological assays. For example, biolo-
gical activity can be expressed quantitatively as in the 
concentration of a substance required to give a cer-
tain biological response. Additionally, when physico-
chemical properties of structures are expressed by 
numbers, one can find a quantitative structure-activity 
relationship between properties and structures. The 
mathematical expression can then be used to predict 
the biological response of other chemical structures. 
QSAR are currently being applied in many disciplines, 
such as drug design and environmental risk asses-
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sment. Using QSAR, an estimate of the activity of a 
chemical from its molecular structure can be obtain-
ed; QSAR offers the possibility for screening a large 
number of chemicals in a short time and at low cost 
[4-7]. 
The benzimidazole nucleus, which is a useful 
structure for further research and for development of 
new pharmaceutical molecules, has received much 
attention in the last decade. Because of their antimic-
robial activities, new benzimidazoles have been syn-
thesized and investigated for medical applications. 
The position and type of the substituents on the benz-
imidazole ring are responsible for the variety of bio-
logical activities. Many derivatives of benzimidazole 
are well known as antibacterial agents, as well as this 
class of compounds have been found to show anti-
microbial activities against Gram-positive and Gram-
negative bacteria, primarily because of the potential 
bio-activity of benzimidazole-based ligands [8-19]. 
So, the incorporation of the imidazole and benzimida-
zole nuclei is an important synthetic strategy in drug 
discovery. 
Synthesis of benzimidazoles fused to another 
heterocyclic ring has also attracted wide spread at-
tention due to their diverse application as antioxidant 
[20,21], antifungal [22], antitubercular [23], anticancer 
[24,25] and antiallergic drugs [26]. Various benzimi-
dazoles are also effective inhibitors of the growth of 
HIV-virus [27,28]. S.O. PODUNAVAC-KUZMANOVIĆ, D.D. CVETKOVIĆ: QSAR MODELING OF ANTIBACTERIAL...  CI&CEQ 17 (1) 33−38 (2011) 
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In view of the above and in continuation of our 
studies on inhibitory activities of benzimidazole deri-
vatives [4-7], [11-18], as well as on correlation of mo-
lecular properties with activity, the objective of this 
investigation was to study the usefulness of QSAR in 
the prediction of the antibacterial activity of benzimi-
dazole derivatives against Gram-negative bacteria 
Pseudomonas aeruginosa. The multiple linear regres-
sion (MLR) models have been developed as mathe-
matical equations which relate chemical structure to 
the inhibitory activity. 
EXPERIMENTAL 
Material and methods 
The investigated compounds (Table 1) were syn-
thesized by procedure described earlier [29]. 
Table 1. Structural formulae of the compounds 
 
Compound R1 R 2 R 3 R 4 
1  CH3 H CH3 CH3 
2  Cl H  CH3 CH3 
3  F H  CH3 CH3 
4  OCH3 H  CH3 CH3 
5  CH3 NH2 H  H 
6  Cl NH2 H  H 
7  F NH2 H  H 
8  OCH3 NH2 H  H 
9  CH3 NH2 CH3 CH3 
10  Cl NH2 CH3 CH3 
11  F NH2 CH3 CH3 
12  OCH3 NH2 CH3 CH3 
Antibacterial investigations 
All the benzimidazole derivatives were evalu-
ated for their in vitro growth inhibitory activity against 
bacteria  Pseudomonas aeruginosa ( АТCC 27853). 
Antibacterial activities of the compounds were tested 
by the disc-diffusion method under standard condi-
tions using Mueller-Hinton agar medium as described 
by NCCLS [30]. 
The investigated isolate of bacteria was seeded 
in the tubes with nutrient broth (NB). 1 cm
3 of seeded 
NB was taken and homogenized in tubes with 9 cm
3 
of melted (45 °C) nutrient agar (NA). The homoge-
nous suspension was poured out in Petri dishes. The 
discs of filter paper (diameter 5 mm) were ranged on 
cool medium. After cooling on formed solid medium, 
2×10
-5 dm
3 of the investigated compounds were pla-
ced by micropipette. After incubation of 24 h in ther-
mostat at 25-27 °C, inhibition (sterile) zone diameters 
(including disc) were measured (in mm). The inhibi-
tion zone diameter over 8 mm indicates the tested 
compound is active against microorganism. Every test 
was done in three replications. 
Minimum inhibitory concentration (MIC) was per-
formed by the agar dilution method according to gui-
delines established by the NCCLS standard M7-A5 [31]. 
The MIC of tested benzimidazoles is defined as 
the lowest concentration of the compound at which no 
growth of the strain as observed in a period of time 
and under specified experimental conditions. Stock 
solutions of the compounds were prepared in dime-
thylformamide (DMF). Further dilutions were perfor-
med with distilled water. The concentration range of 
the compounds tested was between 6.25-125 μg/ml. 
The inoculated plates were than incubated at 35 °C 
for 16-20 h. A control using DMF without any test 
compound was included for each organism. There 
was no inhibitory activity in the wells containing only 
DMF. The MIC values of the benzimidazoles tested 
were obtained as μg/ml. In order to classify the anti-
bacterial activity, we established comparisons with 
antibacterial agents currently employed in therapeutic 
treatment. The MICs were compared with Ampicillin 
and Gentamicin which were screened under similar 
conditions as reference drugs.  
Molecular modelling 
All molecular modeling studies were performed 
by using HyperChem 7.5 software (HyperCube Inc., 
Version 7.5) running on P-III processor [32]. Hyper-
Chem includes a model builder that turns a rough 2D 
sketch of a molecule into 3D. The created 3D models 
were cleaned up and subjected to energy minimiza-
tion using molecular mechanics (MM2). The minimi-
zation is executed until the root mean square (RMS) 
gradient value reaches a value smaller than 0.1 kcal/ 
/mol⋅A. The Austin Model-1 (AM-1) method was used 
for re-optimization until the RMS gradient attains a va-
lue smaller than 0.0001 kcal/mol⋅A using MOPAC. 
The lowest energy structure was used for each mole-
cule to calculate molecular descriptors. 
Descriptors generation 
The numerical descriptors are responsible for 
encoding important features of the structure of the 
molecules and can be categorized as electronic, geo-
metric, hydrophobic, and topological characters. Des-
criptors were calculated for each compound in the 
data set, using the software HyperChem [32], Dragon 
[33], and CS Chem Office Software version 7.0 [34]. S.O. PODUNAVAC-KUZMANOVIĆ, D.D. CVETKOVIĆ: QSAR MODELING OF ANTIBACTERIAL...  CI&CEQ 17 (1) 33−38 (2011) 
 
  35
Since there was a large number of descriptors for 
each compound, Pearson's correlation matrix was 
used as a qualitative model, in order to select the 
suitable descriptors for MLR analysis. The eight des-
criptors which were showing maximum correlation 
with inhibitory activity were chosen for further evalua-
tion. The values of descriptors selected for MLR mo-
del are presented in Table 2 (molar refractivity (MR), 
polarizability (P), molar volume (MV), hydration ener-
gy (HE), total energy (TE), surface area grid (SAG), 
and partition coefficient (log P)). 
Statistical methods 
The complete regression analysis was carried 
out by PASS 2005, GESS 2006, NCSS Statistical 
software [35]. 
RESULTS AND DISCUSSION 
The substituted benzimidazoles were first eva-
luated for in vitro antibacterial activity against Gram- 
-negative bacteria Pseudomonas aeruginosa. The va-
lues of MIC are summarized in Table 3. The screen-
ing results reveal that all the compounds exhibited in 
vitro activity against the tested strain.  
In an effort to determine the role of structural 
features, QSAR study was undertaken. A set of benz-
imidazoles consisting of 12 molecules was used for 
multilinear regression model generation.  
The reference drugs were not included in model 
generation as they belong to a different structural se-
ries. Different physicochemical, steric, electronic, and 
structural molecular descriptors were used as inde-
pendent variables and were correlated with antibac-
terial activity.  
Developing a general model requires a diverse 
set of data, and thereby, a large number of descrip-
tors have to be considered. Descriptors are numerical 
values that encode different structural features of the 
molecules. Selection of a set of appropriate descrip-
tors from a large number of them requires a method, 
Table 2. Values of molecular descriptors used in the regression analysis 
Compound MR  P  MV  HE  TE  DM  SAG  logP 
1  87.25 30.78  811.60 -1.00 27.17  3.98 490.32 4.24 
2  87.69 30.87  804.81 -1.86 26.87 3.974  429.54 4.31 
3  83.10 28.85  777.39 -2.23 27.02 3.976  477.14 3.91 
4  89.34 31.42  841.79 -3.68 28.92 3.978  507.17 3.63 
5  81.56 28.46  744.54 -6.39 26.35 4.464  458.41 3.44 
6  81.99 28.55  736.31 -7.16 26.03 4.427  450.08 3.52 
7  77.40 26.53  704.51 -7.31 26.07 4.428  433.17 3.12 
8  83.65  29.1 771.05 -8.95 27.94 4.429  470.97 2.83 
9  90.12 32.13  844.29 -4.26 27.67 4.428  503.71 4.42 
10  89.24 32.22  833.57 -5.38 27.18 4.409  498.16 4.49 
11  85.97  30.2 802.16 -5.21 27.46 4.410  480.77 4.09 
12  92.27 32.77  871.99 -6.83 29.38 4.406  517.74 3.80 
Table 3. Antibacterial screening summary 
Compound log  (1/cMIC) (experimental) log  (1/cMIC) (predicted) Residual 
1  4.602 4.669 -0.067 
2  4.637 4.672 -0.035 
3  4.609 4.494 0.115 
4  4.328 4.332 -0.004 
5  4.278 4.169 0.109 
6  4.314 4.179 0.135 
7  3.981 4.008 -0.027 
8  3.704 3.837 -0.133 
9  4.627 4.643 -0.016 
10  4.659 4.637 0.022 
11  4.333 4.476 -0.143 
12  4.352 4.305 0.047 
Ampicillin 4.446  –  – 
Gentamicin 5.787  –  – S.O. PODUNAVAC-KUZMANOVIĆ, D.D. CVETKOVIĆ: QSAR MODELING OF ANTIBACTERIAL...  CI&CEQ 17 (1) 33−38 (2011) 
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which is able to discriminate between the parameters. 
Pearson's correlation matrix has been performed on 
all descriptors by using NCSS Statistical Software. 
The analysis of the matrix revealed 8 descriptors for 
the development of MLR model (Table 2). 
Mathematical models were formed by a step-
wise addition of terms. A deletion process was then 
employed where each variable in the model was held 
out in turn and using the remaining parameters mo-
dels were generated. Each descriptor was chosen as 
input for the software package of NCSS and then the 
stepwise addition method implemented in the soft-
ware was used to choose the descriptors contributing 
to the antibacterial activity of benzimidazole deriva-
tives. 
The partition coefficient (log P) tends to correlate 
with antibacterial activity exclusively and the best mo-
noparametric model was found to be the following: 
 
log1/cMIC = 0.518log P + 2.391 
n = 12; r = 0.932; s = 0.085; F = 66.43  (1) 
Addition of HE as an additional parameter to log P, 
increased the correlation coefficient from 0.932 to 
0.951 (Eq. (2)): 
log1/cMIC = 0.415log P + 0.031HE + 2.940 
n = 12; r = 0.951; s = 0.010; F = 42.21  (2) 
It should be noted that the addition of other pa-
rameters to log P and HE does not significantly im-
prove the correlation coefficients. 
From both above presented models, it can be 
concluded that the strong influence of the lipophilicity, 
log P, is important for the antibacterial activity and this 
parameter is usually related to pharmacological ac-
tivity [36,37]. This evidence was clearly described in 
lipid theory advanced by Meyer and Overton. Ac-
cording to this theory, log P is a measure of hydro-
phobicity which is important for the penetration and 
distribution of the drug, but also for the interaction of 
drug with receptors. Therefore, it can be suggested 
that lipophilic properties have to be checked for de-
signing of potent antibacterial agents as they are de-
ciding factors for its activity. 
For the testing of the validity of the predictive 
power of selected MLR model (Eq. (2)) the leave-one-
out technique (LOO technique) was used. The de-
veloped model was validated by the calculation of the 
following statistical parameters: predicted residual sum 
of squares (PRESS), total sum of squares deviation 
(SSY), cross-validated correlation coefficient (r
2
CV), 
and adjusted correlation coefficient (r
2
adj) (Table 4). 
PRESS is an important cross-validation parame-
ter as it is a good approximation of the real predictive 
error of the models. Its value being less than SSY 
points out that the model predicts better than chance 
and can be considered statistically significant. Thus, 
in view of this, model 2 is statistically significant. 
Further, for a reasonable QSAR model, the PRESS/ 
/SSY ratio should be lesser than 0.4. The data pre-
sented in Table 4 indicate that for the developed 
model this ratio is 0.1746. The high value of r
2
CV and 
r
2
adj are the essential criteria for qualifying the QSAR 
model 2 as the best one.  
However, the only way to estimate the true pre-
dictive power of the developed model, the predicted 
log (1/cMIC) values of the investigated benzimidazoles 
were calculated using model 2. The data presented in 
Table 3 show that the observed and the estimated ac-
tivities, by using the model 2, are very close to each 
other. It indicates the good predictability of the esta-
blished model 2. Figure 1 shows the plots of linear 
regression of predicted versus experimental values of 
the antibacterial activity of benzimidazoles here in-
vestigated. 
 
Figure 1. Plot of predicted versus experimentally observed 
antibacterial activity against Pseudomonas aeruginosa. 
Table 4. Cross-validation parameters 
Model  PRESS SSY PRESS/SSY  SPRESS  r
2
CV  r
2
adj 
2  0.1644  0.9417 0.1746 0.1170  0.8254  0.8822 
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To investigate the existence of a systematic er-
ror in developing the QSAR models, the residuals of 
predicted values of the inhibitory activity were plotted 
against the experimental values, as shown in Figure 
2. The propagation of the residuals on both sides of 
zero indicates that no systemic error exists, as sug-
gested by Jalali-Heravi and Kyani [38]. It indicates 
that these models can be successfully applied to pre-
dict the antibacterial activity of this class of molecules.  
 
Figure 2. Plot of the residual values against the experimentally 
observed log (1/cMIC) values. 
CONCLUSIONS 
From the above presented results, we conclude 
that the 1-benzylbenzimidazole derivatives are effec-
tive in vitro against the Gram-negative bacteria Pseu-
domonas aeruginosa. Molecular modeling and QSAR 
analysis were performed to find the quantitative ef-
fects of the molecular structure of the compounds on 
their antibacterial activity. An accurate mathematical 
model was developed for predicting the inhibitory ac-
tivity of some benzimidazole derivatives. The validity 
of the model has been established by the determi-
nation of suitable statistical parameters. The esta-
blished model was used to predict the inhibitory ac-
tivity of the benzimidazoles investigated and close 
agreement between experimental and predicted va-
lues was obtained. The low residual activity and high 
cross-validated  r
2 values (r
2
CV) obtained suggests a 
good predictive ability of the developed QSAR model. 
It indicates the antibacterial activity of series of 1-ben-
zylbenzimidazole derivatives can be successfully mo-
deled using various molecular descriptors. It can be 
concluded that the strong influence of the lipophilicity, 
log P, is important for the antibacterial activity and this 
parameter is usually related to inhibitory activity. 
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NAUČNI RAD 
   QSAR MODELOVANJE ANTIBAKTERIJSKE 
AKTIVNOSTI NEKIH DERIVATA BENZIMIDAZOLA 
Analiza kvantitativne zavisnosti struktura-aktivnost (QSAR) izvedena je na seriji od 12 
derivata benzimidazola u cilju predviđanja antibakterijske aktivnosti ispitivanih jedinjenja 
prema Gram-negativnoj bakteriji Pseudomonas aeruginosa. Za odabir deskriptora i za 
postavljanje modela koji povezuje strukturu sa inhibitornom aktivnošću korišćena je me-
toda višestruke linearne regresije. Na osnovu dobijenih rezultata definisan je model za-
snovan na lipofilnosti (log P) i energiji hidratacije (HE). Prediktivna sposobnost modela 
potvrđena je LOO (leave one out) tehnikom. Dobro slaganje između eksperimentalne i 
teoretski dobijene inhibitorne aktivnosti ukazuje na dobar kvalitet definisanog QSAR modela.
Ključne reči: benzimidazol; molekulski deskriptori; kvantitativna zavisnost struk-
tura-aktivnost; antibakterijska aktivnost; Pseudomonas aeruginosa. 
 
 